Results 11 to 20 of about 21,488 (194)
Impact of Chronic Kidney Disease Severity on Clinical Outcomes After Drug-Eluting Stent Implantation: A Propensity Score-Matched Analysis. [PDF]
Clin CardiolModerate‐to‐severe CKD was associated with higher MACE and renal function deterioration after DES implantation in a propensity score‐matched cohort, supporting CKD‐based cardiorenal risk stratification and closer post‐PCI monitoring. ABSTRACT Background Chronic kidney disease (CKD) is prevalent among patients undergoing percutaneous coronary ...
Zhu H, Jin Q.
europepmc +2 more sources
Heart Views, 2011 Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga +1 more
doaj +1 more source
Coronary Artery Disease, 2019 Approximately, 10-20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated implantation of new-generation DES.A total of 172 ...
Wang, Guozhong +5 more
openaire +3 more sources
Drug-eluting stent in diabetes [PDF]
Sao Paulo Medical Journal, 2007 Long-term evaluation of cardiovascular risk among diabetic patients has shown that the incidence of death due to myocardial infarction among these patients is 20%, whereas among nondiabetic patients it is only 3.5%. Such observations haveled to classifying diabetes as a risk that is equivalent to establi shed coronary artery disease.
Lemos Júnior, Hernani Pinto de +2 more
openaire +4 more sources
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
SAGE Open Medical Case Reports, 2016 Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan +2 more
doaj +1 more source
Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model
Chinese Medical Journal, 2016 Background: Currently available silicone and metallic stents for tracheal stenosis are associated with many problems. Granulation proliferation is one of the main complications.
Ting Wang +5 more
doaj +1 more source
Journal of the Pakistan Medical AssociationObjective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan +3 more
doaj +1 more source
Trials, 2012 Background Neointimal hyperplasia plays a pivotal role in the pathogenesis of in-stent restenosis in patients undergoing percutaneous coronary interventions.
Burzotta Francesco +10 more
doaj +1 more source
Frontiers in Pharmacology, 2020 Drug eluting ureteral stent is an effective means for local drug delivery to the urinary tract. It can potentially solve a variety of upper urinary tract problems, such as stent-related urinary tract infections and discomfort, ureteral stricture, and ...
Hongli Shan +6 more
doaj +1 more source
Anatolian Journal of Cardiology, 2023 Background: This study aimed to systematically review the evidence of drug-coated balloon used in the treatment of acute myocardial infarction and compared with using drug-eluting stent in terms of clinical and angiographic outcomes for a relatively long
Zhen Fang +4 more
doaj +1 more source